Stocks Comparison
Cencora vs NU Skin Enterprises: revenue, profit, margins and growth compared
Cencora brought in $321.3B of revenue in fiscal 2025, NU Skin Enterprises $1.5B in fiscal 2025. Revenue changed by +9.3% at Cencora and -14.3% at NU Skin Enterprises on the year before, so Cencora grew faster. Cencora kept 0.5% of its revenue as net profit, NU Skin Enterprises 10.8%. Free cash flow was $3.2B at Cencora and $46M at NU Skin Enterprises.
Side by side, latest fiscal year
| COR | NUS | |
|---|---|---|
| Fiscal year ended | FY2025 (September 30, 2025) | FY2025 (December 31, 2025) |
| Revenue | $321.3B | $1.5B |
| Revenue growth | +9.3% | -14.3% |
| Net income | $1.6B | $160.2M |
| Net margin | 0.5% | 10.8% |
| Free cash flow | $3.2B | $46M |
| Free cash flow margin | 1.0% | 3.1% |
| Earnings per share (diluted) | $7.96 | $3.18 |
| Cash | $4.4B | $238.6M |
| Debt | $7.7B | $224.2M |
| Price to earnings | 38.6 | 1.5 |
| Market value | $58.6B | $225.4M |
| Dividend yield | 0.72% | n/a |
| Rank by revenue in sector | #3 of 523 · Health care | #122 of 523 · Health care |
Over the years
Questions about Cencora and NU Skin Enterprises
Which is bigger by revenue, Cencora or NU Skin Enterprises?
Cencora is bigger by revenue: $321.3B in fiscal 2025, against $1.5B for NU Skin Enterprises in fiscal 2025.
Which keeps more of its revenue as profit, Cencora or NU Skin Enterprises?
Cencora had a net margin of 0.5% in fiscal 2025; NU Skin Enterprises had 10.8% in fiscal 2025.
Which grew revenue faster, Cencora or NU Skin Enterprises?
In their latest fiscal years revenue changed by +9.3% at Cencora and -14.3% at NU Skin Enterprises.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.